Literature DB >> 8339248

Accumulation of wild type p53 protein in human astrocytomas.

M P Rubio1, A von Deimling, D W Yandell, O D Wiestler, J F Gusella, D N Louis.   

Abstract

We have previously described 10 astrocytomas with accumulation of p53 protein but no mutations in p53 exons 5-8, and we have suggested that they might represent overexpression of wild type protein or mutations in less conserved regions of the gene. To investigate these possibilities further, we studied the tumors with immunohistochemistry for wild type and mutant p53 protein and showed that all cases stained with the wild type PAb 1801 antibody but only one case stained with the mutant-specific PAb 240 antibody. To support the hypothesis that the accumulated p53 protein is wild type in most cases, we used single-strand conformation polymorphism analysis and DNA sequencing to evaluate p53 exons 4, 9, and 10 and did not detect mutations at these loci. Although the product of the MDM2 oncogene binds wild type p53 and may account for p53 accumulation, slot-blot analysis of these astrocytomas did not detect MDM2 gene amplification. Thus, evidence suggests that some astrocytomas may accumulate wild type p53 protein but not as a result of MDM2 gene amplification. Furthermore, PAb 1801 immunohistochemistry may not be an adequate method of screening astrocytomas for p53 mutations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339248

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  27 in total

1.  Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation.

Authors:  G P Nielsen; A O Stemmer-Rachamimov; Y Ino; M B Moller; A E Rosenberg; D N Louis
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas.

Authors:  M J Pykett; J Landers; D L George
Journal:  J Neurooncol       Date:  1997-03       Impact factor: 4.130

3.  p53 protein in pediatric malignant astrocytomas: a study of 21 patients.

Authors:  M B Bhattacharjee; J M Bruner
Journal:  J Neurooncol       Date:  1997-05       Impact factor: 4.130

4.  Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.

Authors:  Eunhyang Park; Sang Wun Kim; Sunghoon Kim; Hyun-Soo Kim; Jung-Yun Lee; Young Tae Kim; Nam Hoon Cho
Journal:  Mod Pathol       Date:  2020-07-08       Impact factor: 7.842

5.  Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors.

Authors:  G Chemeris; A Loktinov; A Rempel; M Schwarz; P Bannasch
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics.

Authors:  M Morita; M K Rosenblum; M H Bilsky; R A Fraser; M R Rosenfeld
Journal:  J Neurooncol       Date:  1996-03       Impact factor: 4.130

7.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 8.  Molecular biology of pediatric gliomas.

Authors:  C Raffel
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

9.  Mutations and immunohistochemistry of p53 and proliferation markers in astrocytic tumors of childhood.

Authors:  D Schiffer; P Cavalla; A Di Sapio; M T Giordana; A Mauro
Journal:  Childs Nerv Syst       Date:  1995-09       Impact factor: 1.475

10.  p53 protein and epidermal growth factor receptor expression in human astrocytomas.

Authors:  R Kordek; W Biernat; J Alwasiak; R Maculewicz; R Yanagihara; P P Liberski
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.